BACE1 and metabolic disease: Restoring the content of S1P in AD mice can regulate metabolic disorders, improve the functions of body cells, alleviate neuroinflammation caused by abnormal content in brain tissue, change the proteolytic activity of β-secrease BACE1, control the production of Aβ protein, and alleviate AD [31].